Literature DB >> 25851455

Sodium MRI of multiple sclerosis.

Maria Petracca1,2, Lazar Fleysher3, Niels Oesingmann4, Matilde Inglese1,3,5.   

Abstract

Multiple sclerosis (MS) is the most common cause of non-traumatic disability in young adults. The mechanisms underlying neurodegeneration and disease progression are poorly understood, in part as a result of the lack of non-invasive methods to measure and monitor neurodegeneration in vivo. Sodium MRI is a topic of increasing interest in MS research as it allows the metabolic characterization of brain tissue in vivo, and integration with the structural information provided by (1)H MRI, helping in the exploration of pathogenetic mechanisms and possibly offering insights into disease progression and monitoring of treatment outcomes. We present an up-to-date review of the sodium MRI application in MS organized into four main sections: (i) biological and pathogenetic role of sodium; (ii) brief overview of sodium imaging techniques; (iii) results of sodium MRI application in clinical studies; and (iv) future perspectives.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  axonal degeneration; multiple sclerosis; sodium MRI

Mesh:

Substances:

Year:  2015        PMID: 25851455      PMCID: PMC5771413          DOI: 10.1002/nbm.3289

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  73 in total

1.  Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5.

Authors:  Joel A Black; Jia Newcombe; Stephen G Waxman
Journal:  Brain       Date:  2010-02-10       Impact factor: 13.501

2.  Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis.

Authors:  Stephen G Waxman
Journal:  Trends Mol Med       Date:  2006-03-30       Impact factor: 11.951

3.  Extracellular space of rat cerebral cortex.

Authors:  D L Woodward; D J Reed; D M Woodbury
Journal:  Am J Physiol       Date:  1967-02

4.  Topography of brain sodium accumulation in progressive multiple sclerosis.

Authors:  Adil Maarouf; Bertrand Audoin; Simon Konstandin; Audrey Rico; Elisabeth Soulier; Françoise Reuter; Arnaud Le Troter; Sylviane Confort-Gouny; Patrick J Cozzone; Maxime Guye; Lothar R Schad; Jean Pelletier; Jean-Philippe Ranjeva; Wafaa Zaaraoui
Journal:  MAGMA       Date:  2013-08-03       Impact factor: 2.310

5.  Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.

Authors:  R Fern; B R Ransom; P K Stys; S G Waxman
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

Review 6.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 7.  Progressive multiple sclerosis: pathology and pathogenesis.

Authors:  Hans Lassmann; Jack van Horssen; Don Mahad
Journal:  Nat Rev Neurol       Date:  2012-09-25       Impact factor: 42.937

8.  A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging.

Authors:  Guillaume Madelin; Richard Kline; Ronn Walvick; Ravinder R Regatte
Journal:  Sci Rep       Date:  2014-04-23       Impact factor: 4.379

Review 9.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  5 in total

Review 1.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

2.  Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Authors:  Wallace J Brownlee; Bhavana Solanky; Ferran Prados; Marios Yiannakas; Patricia Da Mota; Frank Riemer; Manuel Jorge Cardoso; Sebastian Ourselin; Xavier Golay; Claudia Gandini Wheeler-Kingshott; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-04       Impact factor: 10.154

3.  Cerebral sodium (23Na) magnetic resonance imaging in patients with migraine - a case-control study.

Authors:  Melissa M Meyer; Alexander Schmidt; Justus Benrath; Simon Konstandin; Lothar R Pilz; Michael G Harrington; Johannes Budjan; Mathias Meyer; Lothar R Schad; Stefan O Schoenberg; Stefan Haneder
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

4.  Skin sodium is increased in male patients with multiple sclerosis and related animal models.

Authors:  Konstantin Huhn; Peter Linz; Franziska Pemsel; Bernhard Michalke; Stefan Seyferth; Christoph Kopp; Mohammad Anwar Chaudri; Veit Rothhammer; Arnd Dörfler; Michael Uder; Armin M Nagel; Dominik N Müller; Anne Waschbisch; De-Hyung Lee; Tobias Bäuerle; Ralf A Linker; Stefanie Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

Review 5.  Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis.

Authors:  Maria Petracca; Giuseppe Pontillo; Marcello Moccia; Antonio Carotenuto; Sirio Cocozza; Roberta Lanzillo; Arturo Brunetti; Vincenzo Brescia Morra
Journal:  Brain Sci       Date:  2021-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.